A phase 1 dynamic accelerated titration dose escalation study of the vascular disrupting agent NPI-2358

被引：0
|
作者：
Spear, M. A.
LoRusso, P.
Tolcher, A. W.
Lin, C.
Wang, D.
Heath, E.
Lloyd, G. K.
Cropp, G.
Papadopoulos, K. P.
机构：
[1] Nereus Pharmaceut, San Diego, CA USA
[2] Karmanos Canc Ctr, Detroit, MI USA
[3] Inst Drug Dev, San Antonio, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14097
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EXACT Trial: Results of the Phase 1 Dose-Escalation Study
    Povsic, Thomas J.
    Henry, Timothy D.
    Traverse, Jay H.
    Anderson, R. David
    Answini, Geoffrey A.
    Sun, Benjamin C.
    Arnaoutakis, George J.
    Boudoulas, Konstantinos D.
    Williams, Adam R.
    Dittrich, Howard C.
    Tarka, Elizabeth A.
    Latter, David A.
    Ohman, E. Magnus
    Peterson, Mark W.
    Byrnes, Dawn
    Pepine, Carl J.
    DiCarli, Marcelo F.
    Crystal, Ronald G.
    Rosengart, Todd K.
    Mokadam, Nahush A.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (08) : E012997
  • [32] Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors
    Nishikawa, Tadaaki
    Matsumoto, Koji
    Tamura, Kenji
    Yoshida, Hiroyuki
    Imai, Yuichi
    Miyasaka, Aki
    Onoe, Takuma
    Yamaguchi, Satoshi
    Shimizu, Chikako
    Yonemori, Kan
    Shimoi, Tatsunori
    Yunokawa, Mayu
    Xiong, Hao
    Nuthalapati, Silpa
    Hashiba, Hideyuki
    Kiriyama, Tsukasa
    Leahy, Terri
    Komarnitsky, Philip
    Fujiwara, Keiichi
    CANCER SCIENCE, 2017, 108 (09) : 1834 - 1842
  • [33] A phase I study of accelerated radiotherapy for glioblastoma multiforme using stereotactic concomitant boosts for dose escalation
    Chung, T
    Wallace, T
    Cardinale, R
    Broaddus, W
    Benedict, S
    Ramekrishnan, V
    Schmidt-Ullrich, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S265 - S266
  • [34] Accelerated-hypofractionated IMRT plus Temozolomide in Glioblastoma: a phase I dose-escalation study
    Ferro, M.
    Macchia, G.
    Deodato, F.
    Cilla, S.
    Melone, A. C.
    Pagnano, P.
    Ferro, M.
    Boccardi, M.
    Ianiro, A.
    Arcelli, A.
    Cammelli, S.
    Farioli, A.
    Frezza, G. P.
    Ciuffreda, M.
    Sallustio, G.
    Chiesa, S.
    Balducci, M.
    Valentini, V.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S327 - S327
  • [35] Phase I dose escalation study of CVM-1118, a novel anti-vascular mimicry agent, in patients with advanced cancers.
    Tolcher, Anthony W.
    Su, Wu -Chou
    Lakhani, Nehal
    Gutheil, John
    Melink, Teresa J.
    Chu, Yi-Wen
    Chen, Yen-Ling
    Chien, Du-Shieng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] EZN-2208, a novel anticancer agent, in patients (pts) with advanced malignancies: A phase 1 dose-escalation study
    Patnaik, Amita
    Papadopoulos, Kyriakos P.
    Beeram, Muralidhar
    Kee, Debbie
    Tolcher, Anthony W.
    Schaaf, Larry J.
    Tahiri, Sanaa
    Bekaii-Saab, Tanios
    Buchbinder, Aby
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] A phase 1 dose escalation study of lapatinib and paclitaxel in recurrent ovarian cancer
    Cao, Connie D.
    McCorkle, Joseph R.
    Yan, Donglin
    Jayswal, Rani
    Miller, Rachel W.
    Dietrich, Charles S.
    Ueland, Frederick R.
    Kolesar, Jill M.
    CANCER RESEARCH, 2024, 84 (05)
  • [38] A Phase 1 exercise dose escalation study for stroke survivors with impaired walking
    Dite, Wayne
    Langford, Zoe N.
    Cumming, Toby B.
    Churilov, Leonid
    Blennerhassett, Jannette M.
    Bernhardt, Julie
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (07) : 1051 - 1056
  • [39] Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study
    Chen, Jianzhou
    Guo, Hong
    Zhai, Tiantian
    Chang, Daniel
    Chen, Zhijian
    Huang, Ruihong
    Zhang, Wuzhe
    Lin, Kun
    Guo, Longjia
    Zhou, Mingzhen
    Li, Dongsheng
    Li, Derui
    Chen, Chuangzhen
    ONCOTARGET, 2016, 7 (16) : 22711 - 22719
  • [40] A phase 1/1b dose escalation study of iniparib as a single agent and in combination with gemcitabine/carboplatin in patients with advanced solid tumors
    Mita, Monica
    Baffa, Raffaele
    Charpentier, Eric
    Lockhart, Craig A.
    Morris, John C.
    Rixe, Olivier
    Sarantopoulos, John
    Ramanathan, Ramesh
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345